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Restenosis is the main problem limiting long-term success of percutaneous transluminal coronary angioplasty
(PTCA) and is most accurately evaluated by follow-up angiography. We compared the primary and long-term
results of angioplasty in 268 consecutive patients (293 segments) with first PTCA (PTCA 1, angiographic
follow-up 98% ) and in 66patients (76 segments) with repeat PTCA after restenosis (PTCA 2, angiographic
follow-up 92%). Forty clinical, angiographic and procedural factors were assessed in relation to outcome.
Primary success rate was higher in PTCA 2 (91% vs 67-5%) and major complications were fewer (4-5% vs
16%). Higher inflation pressure (7-9±2-3 vs 6-8±l-8atm, P<0005) and larger balloons (3-5±0-5 vs
3-2 ± 0-5 mm, P < 0.005) were used for PTCA 2, resulting in lesser residual stenosis (33 ± 16% vs 40 ± 18%,
P < 0-05). Restenosis rate (^70%) after PTCA I and after PTCA 2 (27% vs 36%, P = NS) and the mean
time to recurrence (4- 7 vs 5-3 months, P = NS) were similar. Procedural factors were the main determinants of
long-term success in primary PTCA. The restenosis risk was independently related to residual stenosis ^45%
(P<0-001), variant angina (P<0-05) and multivessel disease (P<0-05) after PTCA 1 and to male sex
(P<0001) and higher inflation pressure (P<0-05) after PTCA 2. Mild to moderate intimal tearing was
associated with less restenosis after PTC A 1, but not after PTCA 2. Including 9 patients (10 segments) with a
third PTCA, 70% of the 66 patients with repeat PTCA had a successful long-term outcome. Repeat angio-
plasty should therefore be considered as an integral part of PTCA therapy. Restenosis however remains a
major concern. An optimal primary result with a minimal residual stenosis is decisive for first PTCA, whereas
avoidance of a dissection by using lower inflation pressure on a restenosis might improve the long-term outcome
of repeat PTCA.
Since its introduction'1 2 ' successful percutaneous long-term success of PTCA. Reported restenosis
transluminal coronary angioplasty (PTCA) has rates (14 -47%) vary, depending in part on the den-
been shown to relieve angina and myocardial nition used, but according to the larger series'18"22',
ischaemia as assessed by exercise electrocardiog- one patient in three with successful PTCA must
raphy13', thallium scintigraphy*3'4', and measure- expect recurrence, most of them within 6-8 months
ment of coronary blood flow and myocardial after the intervention. Repeat PTCA has been
metabolism'5 '6 '. The original indications'2 ' have been done with a higher primary success rate and fewer
expanded'7"171. But regardless of selection criteria, complications than the initial procedure. Neverthe-
restenosis with recurrence of myocardial ischaemia less, there remains a substantial rate of second
and symptoms remains the major problem limiting recurrences'23"251.
The presence of angina as an indicator for
restenosis has a predictive accuracy of only 56%
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order to evaluate the value of a repeat procedure, as
stated in the NHLBI report"8-31 and by others'261.
This study, based on an angiographic follow-up
of 98% and 92%, respectively, of the patients,
reports on our long-term results of first and of
repeat PTCA. Factors related to restenosis after
both conditions and their impact on procedural
recommendations are discussed.
Methods
STUDY POPULATION (REPEAT PTCA)
Between February 1980 and February 1984, 609
consecutive patients underwent PTCA at the
Montreal Heart Institute. Among them 66 patients,
52 men and 14 women, had a second PTCA (PTCA
2) on the same coronary segment because of
restenosis after an initially successful procedure.
Ten patients had a repeat PTCA on two segments.
Nine patients underwent a third PTCA (PTCA 3)
because of restenosis on an initially successful
second PTCA, one of them on 2 segments. Figure 1
summarizes results and follow-up of the patients
with repeat angioplasty.
REFERENCE POPULATION (FIRST P T C A )
Among our first consecutive 268 angioplasties
(February 1980 until March 1983) 181 were pri-
marily successful and 178 of them (98%) had an
angiographic follow-up. Since that time, we have
not performed control angiography systematically
on patients with a first successful and uncompli-
cated PTCA of a single coronary vessel, that are
asymptomatic and had a negative stress test in
their follow-up. To avoid a bias by the selection of
PTCA 2 primary results
PTCA 2 long-term results
PTCA 3 primary results
PTCA 3. long-term results
I | Success with angiogrophic control
tijjjj Success without angiographic control
• • Failure or restenosis with
^ * angiographic control
inn j Failure or restenosis without
•=21 angiographic controlCABG I
Figure 1 Results and follow-up of repeat PTCA in 66 patients (76 coronary segments).
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Table 1 Variables entering univariale analysis
Clinical Angiographic Procedural
Age
Sex
History of smoking
cholesterol > 250 mgdl" 1
triglycendes > 170 mg dl"
hypertension
diabetes
CAD in the family
History of prior MI
prior CHF
CABG
unstable angina
Duration of angina
Duration of actual level of angina
Angina: stable on effort
unstable, excl variant
variant
Hospital stay
Post PTCA treatment
Extent CAD (1-2-3 vessel disease)
Regional left ventricular wall motion
Left ventricular ejection fraction
Stenosis: site (LAD, CX, RCA, graft;
prox, mid/distal)
seventy (%), pre- and post-PTCA
morphology (discrete, tubular,
diffuse)
geometry (concentric, excentric)
calcification
involved branch
Collaterals
Number of segments attempted
Catheter type
Pre and post PTCA gradient
Largest balloon used
Maximal inflation pressure
Number of inflations
Ratio of diameters inflated
balloon/nondiseased artery
Coronary dissection (mild,
moderate, severe, occlusion)
Complications
angiographically controlled patients, we compare
therefore our repeat PTCA with the first consecutive
268 initial procedures.
Table 1 shows the forty clinical, angiographical
and procedural variables assessed for their discrimi-
nant and predictive value of primary and long-term
success in PTCA 1 and PTCA 2.
PTCA PROCEDURE AND ADJUNCTIVE THERAPY
Angioplasty was performed by femoral approach
following a previously described protocol'271 and
using steerable catheters since April 1982. The
percent severity of the stenosis pre- and post-PTCA
was evaluated angiographically in several angu-
lations. In addition, the absolute luminal diameter
of the adjacent healthy coronary segment was
measured pre-PTCA, corrected for X-ray magnifi-
cation by comparing it with the shadow of the 8F
catheter (2-7 mm). Since the real balloon size
exceeds the one given by manufacturers with press-
ures above 6 atmospheres'281, the balloons were
measured immediately after the procedure, inflated
at the maximal pressure used. As a consequence of
previous analyses'291 the inflation pressure used
tended to be higher (8-12 atm) and balloons larger
during 1984 with the goal of achieving a ratio of 11
to 1-3 in the diameters of inflated balloon/adjacent
healthy coronary segment, which we believe to be
optimal'281.
All patients were treated with platelet-inhibitors
(either sulfinpyrazone 200mgq.i.d. or aspirin
650 mg plus dipyridamole 75mgt.i.d.) for six
months after successful PTCA. Diltiazem,
90mgt.i.d. in addition to anti-platelet treatment
was given systematically for 3 months during a
randomized trial in 1982/19831301 but, based on
physicians' preference, only intermittently since.
FOLLOW-UP
The mean clinical follow-up after PTCA 1 was
14-2±11 months, and after PTCA 2 l l-6±7
months. It included exercise stress tests, usually at 3
and 6 months after the intervention. No patient was
lost to follow-up. 178 of the 181 patients with a
successful PTCA 1 (98%) had a control angio-
graphy 10-6 ± 6-8 months after the intervention, and
so did 55 of the 60 patients (92%) 9 + 7 months after
a successful PTCA 2. Six patients refused control
angiography. In 2 patients it was not done after
PTCA 2 because of complications previously.
The time of angiographic control was chosen to
compare the time interval to recurrence after and
repeat PTCA, since the information on reappear-
ance of symptoms, especially in the presence of
persisting atypical pains, was not precise in a number
of cases. Control angiography, however, was done
early (within 1-4 weeks) after reappearance of
symptoms.
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CRITERIA FOR SUCCESS AND RESTENOSIS
Primary success of PTCA was defined as ^20%
stenosis reduction without a major inhospital
complication.
Restenosis was defined as reappearance of a
successfully dilated stenosis to ^ 70% in the angu-
lation showing maximum severity of the lesion.
Each restenosis definition, including those proposed
by the NHLBI, have shortcomings as shown by
comparing them to each other1'8'. Our restenosis
definition is based on a percent severity that
we believe to be of clinical relevance. With an
angiographic follow-up of 98% for the PTCA 1
population and of 92% for the redilated patients,
assessment of short and long term success is based
exclusively on angiographic data, unless otherwise
mentioned.
STATISTICAL ANALYSIS
To compare baseline and follow-up character-
istics, univariate analysis was performed using the
chi-square test for categorical data and the Student
/-test for continuous data. A stepwise logistic
regression analysis identified among the univariately
significant variables those with an independent
discriminant or predictive value, using primary suc-
cess and restenosis (definitions above) as outcome
variables. BMDP software was used for statistical
testing.
Results
PATIENT CHARACTERISTICS
The baseline characteristics of both PTCA 1 and
PTCA 2 patients are shown in Table 2. Sixty-six
patients underwent a second intervention for
restenosis 4-7 ±4 months after the first one. Their
mean age was 53-4 years. Seventy-nine percent were
men. Fourteen percent had suffered a prior myo-
cardial infarction and 9% had undergone previous
coronary artery bypass grafting (CABG). Stable
angina on effort was present in 63%, whereas 37%
of the patients were in an unstable condition,
including 12% with variant angina'3'1. One vessel
disease was present in 83% and abnormal regional
left ventricular wall motion in 30%.
Although the mean age was higher in the popu-
lation that underwent repeat PTCA compared to
the PTCA 1 population (53-4± 10 vs 50-8±10
years, P = 005), the percentage of patients above 60
years in both groups was not significantly different.
There was a trend for more men and more variant
angina in the PTCA 2 group, but no other signifi-
cant difference in the baseline characteristics of the
patients.
REPEAT PTCA PROCEDURE
Compared to the first PTCA in the same patients
several factors of the second procedure changed
significantly (Table 3): larger balloons (mean
3-5 mm vs 3-2 mm, P< 0-005) with a higher ratio
of diameters inflated balloon/nondiseased artery
(mean 104 vs 0-95, P = 007) and higher inflation
pressure (mean 7-9 vs 6-8 atmospheres P< 0-005)
were used. The resulting residual stenosis was less
(mean 33% vi40%, P<005).
PRIMARY RESULTS OF PTCA 1/PTCA 2 AND THEIR
PREDICTORS
The immediate outcome of both PTCA 1 and
PTCA 2 is summarized in Table 4. The primary
success rate of PTCA 2 was 91% (60/66) of the
patients and 92% (70/76) of the segments which was
significantly higher than in the PTCA 1 population
(181 /268 patients = 67-5% and 205/293 segments =
70%, respectively). Failures were due to inability to
Table 2 Baseline characteristics of the patients with first and
repeat PTCA
No. of
patients (coronary segments)
Age (years)
Men
Prior myocardial infarction
Prior bypass graft
Stable effort angina
Unstable (excl variant) angina
Variant angina
Single vessel disease*
Multivessel disease*
LAD
LCX
RCA
CABG
Abnormal regional wall motion
PTCA 1
268(293)
5O-6±9-7
73%
13%
6%
69%
23%
8%
85%
15%
65%
8%
23%
4%
23%
PTCA 2
66(76)
53-4±10
79%
14%
9%
63%
25%
12%
83%
17%
63%
14%
20%
3%
30%
* ? 70% stenosis on major coronary artery or > 50% on left
main stem.
LAD — left anterior descending, LCX — circumflex,
RCA — right coronary artery, CABG — coronary artery
bypass graft.
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Table 3 Differences between first and second procedures in patients with repeat PTC A
(N = 66 patients or 76 coronary segments)
PTCA1 PTCA2 Pvalue
Largest balloon used (mm)
Maximal inflation pressure (atm)
Residual stenosis (%)
Ratio of diameters inflated balloon/
undiseased artery
3-2±0-5
6-8 ±1-8
400±180
0 95 ±0-2
3-5±O-5
7-9±2-3
330±16 0
l-04±0-2
< 0-005
< 0-005
<0.05
= 007
Table 4 Results of first and repeal PTC A
All patients (coronary segments)
primary success
failure: lesion non traversed
non dilatable
occluded
complications: in hospital death
infarction
emergency CABG
one of the above
Patients (coronary segments) with
angiographic control
long term success
restenosis
N
268 (293)
181(205)
( 58)
( 7)
( 23)
19
36
43
178(202)
130(154)
48 ( 48)
PTCA 1
%
100
67-5 (70)
(20)
( 2)
( 8)
7
13
16
100
73(76)
27(24)
N
66(76)
60(70)
( 3)
( 3)
-
2
1
3
55(65)
35(41)
20 (24)
PTCA 2
%
100
91 (92)
( 4-5)
( 4-5)
-
3
1-5
4-5
100
64(63)
36(37)
cross the stenosis (4-5% in PTCA 2, 20% in PTCA
1), early occlusion (4-5% in PTCA 2, 8% in PTCA
l)and nondilatable lesions (none in PTCA 2,2% in
PTCA 1).
Significantly fewer major complications occurred
due to PTCA 2 compared to PTCA 1 (myocardial
infarction 3% vs 7%, emergency coronary artery
bypass grafting 1-5% vs 13%, no in hospital death;
overall4-5% vs 16%, P<005).
Due to considerable improvement in PTCA
materials since 1982 (steerable catheters, low pro-
file balloons) and growing experience (e.g. in the
decision to perform emergency bypass grafting) the
primary results in the PTCA 1 group do not reflect
the present standard and should therefore only
cautiously be compared with the PTCA 2 group.
Nevertheless, the primary results in the PTCA 2
subgroup treated during the same period as the
PTCA 1 group (Feb 1980-March 1983: J V = 3 5 ,
success rate 32/35 = 91%, major complications
1/35 = 2-9%) had already reached that excellent
standard.
Factors that were independently related to
primary success in our PTCA 1 group are not men-
tioned here, since they might no longer be relevant
with the new materials available. The number of
failures in the PTCA 2 group is too small to evaluate
factors influencing the immediate outcome.
LONG-TERM RESULTS OF PTCA 1/PTCA 2 AND THEIR
PREDICTORS
Restenosis >70% was angiographically docu-
mented in 48/178 (27%) patients or 48/205 (24%)
coronary segments at a mean of 4-7 ± 4 months after
successful PTCA 1. The use of the NHLBI defin-
ition of restenosis'181 would have added two more
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Table 5 Factors significantly related to restenosis after first PTCA
N Restenosis Lasting success
rates, except* rates, except* P value
Overall results
Patients (coronary segments) with angiographic
control after successful PTCA 1
Univariate analysis of subgroups
Residual stenosis
Coronary lesion: one vessel disease, fixed
one vessel d. + variant angina
multivessel disease
Coronary dissection by PTCA. no
mild
moderate
severe
Calcification artery: yes
no
Ratio diameter inflated balloon/artery
Number of inflations with largest balloon
178 (202)
(202)
134
20
24
(110)
( 19)
( 64)
( 9)
( 50)
(152)
(202)
(202)
27% (24%)
*48±14%
20%
45%
46%
(27%)
( 5%)
(17%)
(55%)
(34%)
(20%)
*0-98±0-2
•5-1 ±2-9
Multivariate analysis
Residual stenosis ^ 4 5 %
Coronary lesion: one vessel disease with variant angina or multivessel disease
Coronary dissection by PTCA: none or severe
Ratio of diameters inflated balloon/artery < 1
73% (76%)
•36 ± 1 3 %
80%
55%
54%
(73%)
(95%)
(83%)
(45%)
(66%)
(80%)
*l-06±0-2
*4-2±2-4
< 0-001
<0 005
<001
<005
<005
<005
/"-value
< 0-001
<005
$007
= 007
patients. 84% of the restenoses occurred within 6
months, 96% within 8 months. The restenosis rate
after PTCA 2 tended to be higher: 20/55 (36%)
patients or 24/65 (37%) segments (/> = NS for
patients, = 005 for segments). The mean interval to
restenosis after PTCA 2 was 5-3 + 5 months, with
76% of the recurrences within 6 months and 88%
within 8 months after the intervention (/>=NS vs
PTCA 1).
Factors that favoured restenosis after PTCA 1
according to uni- and multivariate analysis of 40
variables (Table 1) are listed in Table 5. The resteno-
sis group was characterized by a higher degree of
residual stenosis immediately after PTCA (mean
48 ± 14% with 29/48 segments between 50 and 60%
vs mean 36 ±13% with only 28/154 segments
between 50 and 60% in the group with lasting
success, />< 0-001), a smaller ratio in the diameters
of inflated balloon/adjacent healthy coronary seg-
ment (0-98±0-2 vs 1 06±0-2, P<005) and more
inflations (5-1 ±2 9 vs 4-2±2-4 P<005). Other
factors predicting a high restenosis rate were: variant
angina (45%), multivessel disease (46%), a calcined
artery (34%) and a severe intimal dissection (55%).
Interestingly, a mild dissection led to significant less
restenosis than no visible dissection (5% vs 27%,
P < 001). Among variables not related to restenosis
were the coronary risk factors, the clinical ante-
cedents, gender and age. The multivariate analysis
selected three independent predictors of restenosis
after PTCA I: a residual stenosis of 45% or
more (/"< 0-001), the presence of variant angina
(/><0-05) and multivessel disease (/><005). The
degree of dissection produced by PTCA and the
ratio in diameters of inflated balloon/artery almost
reached statistical significance (/> = 007 each).
The same forty variables (Table 1) were assessed
for their predictive value of restenosis after PTCA 2
(Table 6). The restenosis group was characterized
by the use of higher inflation pressure (9 ±2 vs
7±2atm, /><0-005) and a high initial gradient
(57±15 v* 45±15mmHg, P<0Q5). Only men
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Table 6 Factors significantly related to restenosis after repeat PTC A
N Restenosis
rates, except*
Lasting success
rates, except' /•value
Overall results
Patients (coronary segments) with angiographic
control after successful PTCA 2
Univariate analysis of subgroups
Sex: male
female
Inflation pressure
Coronary dissection by PTCA: no
mild
moderate
Extent of coronary disease' one vessel
multivessel
Initial gradient before PTCA
Multivariate analysis
Male sex
Inflation pressure > 8 atm
55(65)
43
12
(62)
(35)
(26)
( 4)
35
20
49
36% (37%)
47%
0%
*8-9±2-4atm
( 26%)
( 42%)
(100%)
23%
60%
•57±15mmHg
64% (63%)
53%
100%
•7 ±1-9 atm
(74%)
(58%)
( 0%)
77%
40%
•45±15mmHg
<0001
<0005
<0-01
<0 05
<0-05
lvalue
< 0-001
<005
suffered a second recurrence (restenosis rate 47% vs
0% for female, />< 0-001). Other factors related to
a high restenosis risk were: a mild or moderate
intimal dissection (restenosis rate 42% and 100%,
respectively, vs 26% with no dissection, P<005)
and multivessel disease (60% vs 23% in one vessel
disease, P<005). The trend of a higher recurrence
rate in patients with prior unstable (57%) or variant
angina (50%) was not significant, probably because
of the small size of the subgroups (N= 14 and 6,
respectively).
Multivariate analysis retained male sex
(P < 0001) and a higher inflation pressure {P < 005)
as indepedent predictors of restenosis after PTCA
2.
When the clinical results of patients without
angiographic control (3 asymptomatic, 2 atypically
symptomatic but with positive exercise stress test)
are taken into account, the recurrence rate after
PTCA 2 does not change (22/60 = 36-6%).
THIRD PTCA
Of the 20 patients with a second recurrence after
PTCA 2, 9 underwent a third PTCA (PTCA 3), 6
had elective coronary artery bypass grafting and 5
were controlled with medical treatment (see Fig. 1).
PTCA 3 was primarily successful in all patients.
Follow-up based on angiograms (6 patients), exer-
cise stress tests (1 patient) and interviews (2 patients)
demonstrated sustained success and absence of
symptoms in 8 of 9 patients. One patient, with 3
consecutive PTCAs and restenoses on the proximal
segment of a venous bypass graft had a reoperation.
Thus, analyzing PTCA 2 and 3 together, repeat
angioplasty in 66 patients with restenosis after the
first intervention resulted in lasting success in 70%
of them (41 of 58 patients with angiographic follow-
up or 46 of all 66 patients with clinical follow-up).
Discussion
PATIENTS
The patients undergoing repeat PTCA had base-
line characteristics similar to the patients with single
or initial PTCA. The trend of more men having a
second angioplasty is in line with the other two
series published so far123-241. The high incidence of
variant angina in PTCA 2 patients might be due to
our research interest in that area'1731' and the high
restenosis rate among those patients'171.
PROCEDURE
The fact that larger balloons with higher inflation
pressure were used for the second PTCA, leading
to a higher ratio of diameters inflated balloon/
nondiseased artery and lesser residual stenosis,
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reflects our1281 and others'32-331 experience, that these
procedural factors are more important determi-
nants of immediate PTCA success than the clinical
or angiographic pattern.
PRIMARY RESULTS
A second PTCA, performed because of restenosis
had a higher primary success rate than a first pro-
cedure (91 vs 67-5%, much like that in the other
series (85% vs 61 %(231,97 vs 85%'24), 96%|26]. Major
complications were fewer, also in agreement with
published reports123"241. The reasons for both include
the improvement in PTCA material since 1982, the
increasing experience of the operators and the selec-
tion of a PTCA 2 population with lesions suitable
for a successful intervention. The primary results
of our PTCA 1 group 1980-1983 certainly do not
reflect the current standard. Furthermore the
number of patients (especially of failures) in PTCA
2 group is small. Factors influencing the immediate
outcome of both PTCA 1 and PTCA 2 are therefore
not discussed here.
LONG-TERM RESULTS
Restenosis remains a major concern limiting
long-term success of both first and repeat PTCA in
spite of improved primary results. The lowest pub-
lished restenosis rate in a larger series with an angio-
graphical follow-up comparable to ours was 17%
after initial and 33% after repeat PTCA1201. In most
other series of first PTCA a higher recurrence rate
between 25% and 35%1'8'"-21-221 was documented
with a less complete angiographic follow-up, but in
agreement with the 27% of our PTCA 1 group.
The restenosis rate tends to be even higher
after repeat PTCA (36%), as shown by others as
wel]P3-25i T h i s i s a l s o t m e f o r t h e p j c A 2 per-
formed since March 1983, and therefore indepen-
dent of technical improvement, but not surprising
for a selected population at high risk of restenosis.
In the NHLBI study1231 24% of the patients had
clinical events and 52% were symptomatic after a
second PTCA. In the Atlanta experience124', 26% of
the patients were not improved clinically after a
mean of 8-5 months. The Mid America Heart Insti-
tute reported a higher restenosis rate (37%) after
repeat angioplasty*251. With an angiographic follow-
up of 48%(23) and 61%(24) (not detailed in1251), the
restenosis rates (34%(23>, 41 %1241, 37%'25]) in these
respective series might not be representative of the
total PTCA 2 population. If, as suggested by the
Atlanta study1241, the mean time interval between
intervention and recurrence lengthens after repeat
PTCA, a more complete angiographical follow-up
might have revealed restenoses not yet clinically
apparent. In our study, however, the time to recur-
rence was similar after PTCA 1 (4-7 ±4 months)
and PTCA 2 (5-3 ± 5 months) with 96% and 85% of
the restenoses being demonstrated within 8 months
after the intervention.
RESTENOSIS RISK FACTORS
Non procedural factors
Unstable and especially variant angina indepen-
dently increased the restenosis risk after primary
PTCA, in agreement with other reports'18-2'1.
Multivessel disease was related to restenosis after
both first and repeat PTCA (cf ref.1221). Male sex
was a strong risk factor of recurrence after repeat
PTCA. This contrasts with the higher bypass
patency reported in men'34351, but confirms the
data of the NHLBI registry"81. Other published
associations with a high restenosis risk, such as dia-
betes"8-221, PTCA of occluded vessels"4-2'1 or PTCA
of a proximal vein graft stenosis"3-361 could not be
verified due to small subgroups in our series.
Dilated stenoses on the left anterior descending
artery did not recur more often than those on the
circumflex or the right coronary artery, as reported
by others'2'-221; the use of an adequate balloon
size after measuring the luminal diameter of the
adjacent healthy coronary segment (see Methods)
might have prevented this.
Procedural factors
Procedural factors of PTCA seem to be the main
determinants of its long term outcome.
The residual stenosis, especially when >45%,
was the main predictor of restenosis after first
PTCA. The importance of the immediate result has
been emphasized by other groups as well121'221. A
severe intimal dissection increased the recurrence
risk, but no visible dissection as well. We believe like
others'21*221 that mild intimal tearing is an angio-
graphic marker that predicts a good long term result
in primary PTCA. The choice of an adequate balloon
size is thereby important. A ratio of diameters
inflated balloon/undiseased artery < 1 increased the
restenosis risk, 1-1-1-3 being optimal'281. The un-
predictable resistance and histology of the plaque to
be treated certainly also determines the inflation
pressure needed and the extent of the resulting
dissection.
For repeat PTCA higher inflation pressure and
even mild intimal dissection led to more restenosis
(a) (b)
(c) (d)
(e) (f)
(g)
Figure 2 Angiographic pattern of restenosis post-PTC A and repeal PTCA
Sixty-three year old man with single vessel disease. The angulation for all frames is RAO 15°/25° caudal,
except for e and f (RAO 30')- (a) April 1983 — excentric short stenosis of 75% on proximal LAD; (b)
immediate result of PTCA 1 (balloon 3-7 mm, 4 atm): residual stenosis of 20%, no visible dissection; (c)
October 1983 — restenosis of 60%, longer and smoother than the original stenosis; (d) immediate result
of PTCA 2 (balloon 4-3 mm, 12 atm): residual stenosis of 25%, long dissection without impairment
of flow; (e) February 1984 —restenosis of 60%, long and irregular; (f) immediate result of PTCA 3
(balloon 3-5 mm, 8 atm): residual stenosis of 30%, no visible dissection; (g) September 1984 — control,
no significant restenosis.
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in spite of a good primary result. This point deserves
special attention. If we are dealing with a different,
more compilable histological substrate in repeat
PTCA, the use of lower inflation pressure might
indeed be optimal. In PTCA on an original hard
atheromatous plaque, disruption of the internal
elastic membrane and overstretching of the muscu-
lar media with some cellular damage under high
pressure is probably essential for success'37!. ]n
repeat PTCA, however, it might be sufficient to
distend and perhaps compress to some degree the
proliferating fibrocellular neointima with lower
pressure.
No drug regimen was associated with a signifi-
cantly lower recurrence rate after primary or repeat
PTCA. That was also true for other retrospective
studies'18"21'. According to prospective trials, aspirin
is at least as effective as coumadin in preventing
restenosis after PTCA'381 and diltiazem does not
decrease the recurrence rate in patients without
variant angina'30'. Calcium antagonist therapy how-
ever, seems to reduce the high restenosis risk of
PTCA in patients with variant angina'171.
PATHOLOGY OF RESTENOSIS
The difference in procedural risk factors for
restenosis after primary and repeat PTCA seems
rational if the histology of restenosis differs from
the original lesion. Although a few histological case
reports of restenosis 3—6 months after PTCA have
documented recurrent lesions indistinguishable
from de novo atherosclerosis'39' others have shown
restenosis by fibrocellular proliferation only*40-41'
resembling more the experimental model'42'.
Restenosis by intimal fibrous hyperplasia only has
also been described after venous bypass angioplasty
performed early (2 months) after graft insertion143'
whereas vein graft stenoses occurring beyond one
year after insertion are known to consist of typical
atherosclerotic plaque144'. It is a common experience
that restenoses are more symmetrical and smoother
in their angiographic appearance (see Fig. 2) and
less resistant when being dilated, suggesting that the
consistency and histology indeed differ from the
original lesions. The role of platelets in coating a
damaged surface immediately after PTCA'45"47] and
that of thrombus organization'42' has been demon-
strated for restenosis in the animal model. Intimal
proliferation of smooth muscle cells seems to be the
main mechanism of recurrence in man'40"41"43'. It can
be triggered by platelet-derived growth factors, but
might also be provoked by the balloon injury itself
independently of serum factors'481 and thus even
under antiplatelet or anticoagulant drugs. Spasm is
probably not the major stimulus of restenosis in
patients without variant angina'30', but occurs early
after PTCA[49>.
THIRD PTCA
Our number of third angioplasties performed on
the same restenosing segment is too small to draw
firm conclusions. However, a majority of this highly
selected population (8/9 in our experience, 6/7 in the
Atlanta report'24' 13/23 in the series of the Mid
America Heart Institute'251 seems to have a favour-
able long term outcome. The only restenosis after
PTCA 3 we experienced was on the proximal part of
a venous bypass graft.
Conclusions
Restenosis after PTCA remains a major problem.
Besides some inherent risk factors such as male sex,
variant angina and multivessel disease, procedural
factors are the main determinants of long-term
success in PTCA. An optimal primary result with a
minimal residual stenosis, that might well include
mild intimal tearing, is important for first PTCA,
whereas avoidance of any visible dissection by using
lower inflation pressure on a restenosis of probably
different histology could improve the long-terrn
outcome of repeat PTCA. Repeat PTCA in patients
with restenosis after a first procedure has a high
primary success rate, and complications are rare.
Although the restenosis rate after a second angio-
plasty is at least as high as after the first inter-
vention, 70% of the patients with repeat PTCA
have a successful long-term outcome, if one
includes third interventions. Women seem to do
better than men. Thus, repeat angioplasty should be
considered as an integral part of PTCA therapy.
Addendum
Up to 15 November 1984, 136 coronary segments
in 117 patients were redilated because of a restenosis
at the Montreal Heart Institute. The overall
primary success rate was 91 %. Of the 95 segments
successfully dilated before 15 May 1984, 82 (86%)
were angiographically controlled within 6 months
(by 15 November). Restenosis > 70% was present
on 27 (33%) of the segments. No recurrence
occurred after a successful second PTCA in women
{N=\iy
The above conclusions, therefore remain valid
for our entire experience.
We acknowledge the excellent secretarial assistance of
Heidi Schuppbach in the preparation of this manuscript.
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